Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Tasigna Market Growth 2022-2028

  • LP 4871324
  • 76 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Tasigna will have significant change from previous year. According to our (LP Information) latest study, the global Tasigna market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tasigna market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Tasigna market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tasigna market, reaching US$ million by the year 2028. As for the Europe Tasigna landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Tasigna players cover Novartis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Tasigna market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

50mg

200mg

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Drugs Store

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novartis

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tasigna Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tasigna by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tasigna by Country/Region, 2017, 2022 & 2028

2.2 Tasigna Segment by Type

2.2.1 50mg

2.2.2 200mg

2.2.3 Other

2.3 Tasigna Sales by Type

2.3.1 Global Tasigna Sales Market Share by Type (2017-2022)

2.3.2 Global Tasigna Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tasigna Sale Price by Type (2017-2022)

2.4 Tasigna Segment by Application

2.4.1 Hospital

2.4.2 Drugs Store

2.4.3 Other

2.5 Tasigna Sales by Application

2.5.1 Global Tasigna Sale Market Share by Application (2017-2022)

2.5.2 Global Tasigna Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tasigna Sale Price by Application (2017-2022)

3 Global Tasigna by Company

3.1 Global Tasigna Breakdown Data by Company

3.1.1 Global Tasigna Annual Sales by Company (2020-2022)

3.1.2 Global Tasigna Sales Market Share by Company (2020-2022)

3.2 Global Tasigna Annual Revenue by Company (2020-2022)

3.2.1 Global Tasigna Revenue by Company (2020-2022)

3.2.2 Global Tasigna Revenue Market Share by Company (2020-2022)

3.3 Global Tasigna Sale Price by Company

3.4 Key Manufacturers Tasigna Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tasigna Product Location Distribution

3.4.2 Players Tasigna Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tasigna by Geographic Region

4.1 World Historic Tasigna Market Size by Geographic Region (2017-2022)

4.1.1 Global Tasigna Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tasigna Annual Revenue by Geographic Region

4.2 World Historic Tasigna Market Size by Country/Region (2017-2022)

4.2.1 Global Tasigna Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tasigna Annual Revenue by Country/Region

4.3 Americas Tasigna Sales Growth

4.4 APAC Tasigna Sales Growth

4.5 Europe Tasigna Sales Growth

4.6 Middle East & Africa Tasigna Sales Growth

5 Americas

5.1 Americas Tasigna Sales by Country

5.1.1 Americas Tasigna Sales by Country (2017-2022)

5.1.2 Americas Tasigna Revenue by Country (2017-2022)

5.2 Americas Tasigna Sales by Type

5.3 Americas Tasigna Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tasigna Sales by Region

6.1.1 APAC Tasigna Sales by Region (2017-2022)

6.1.2 APAC Tasigna Revenue by Region (2017-2022)

6.2 APAC Tasigna Sales by Type

6.3 APAC Tasigna Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tasigna by Country

7.1.1 Europe Tasigna Sales by Country (2017-2022)

7.1.2 Europe Tasigna Revenue by Country (2017-2022)

7.2 Europe Tasigna Sales by Type

7.3 Europe Tasigna Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tasigna by Country

8.1.1 Middle East & Africa Tasigna Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tasigna Revenue by Country (2017-2022)

8.2 Middle East & Africa Tasigna Sales by Type

8.3 Middle East & Africa Tasigna Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tasigna

10.3 Manufacturing Process Analysis of Tasigna

10.4 Industry Chain Structure of Tasigna

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tasigna Distributors

11.3 Tasigna Customer

12 World Forecast Review for Tasigna by Geographic Region

12.1 Global Tasigna Market Size Forecast by Region

12.1.1 Global Tasigna Forecast by Region (2023-2028)

12.1.2 Global Tasigna Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tasigna Forecast by Type

12.7 Global Tasigna Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Tasigna Product Offered

13.1.3 Novartis Tasigna Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Tasigna Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tasigna Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 50mg

Table 4. Major Players of 200mg

Table 5. Major Players of Other

Table 6. Global Tasigna Sales by Type (2017-2022) & (MT)

Table 7. Global Tasigna Sales Market Share by Type (2017-2022)

Table 8. Global Tasigna Revenue by Type (2017-2022) & ($ million)

Table 9. Global Tasigna Revenue Market Share by Type (2017-2022)

Table 10. Global Tasigna Sale Price by Type (2017-2022) & (USD/Kg)

Table 11. Global Tasigna Sales by Application (2017-2022) & (MT)

Table 12. Global Tasigna Sales Market Share by Application (2017-2022)

Table 13. Global Tasigna Revenue by Application (2017-2022)

Table 14. Global Tasigna Revenue Market Share by Application (2017-2022)

Table 15. Global Tasigna Sale Price by Application (2017-2022) & (USD/Kg)

Table 16. Global Tasigna Sales by Company (2020-2022) & (MT)

Table 17. Global Tasigna Sales Market Share by Company (2020-2022)

Table 18. Global Tasigna Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Tasigna Revenue Market Share by Company (2020-2022)

Table 20. Global Tasigna Sale Price by Company (2020-2022) & (USD/Kg)

Table 21. Key Manufacturers Tasigna Producing Area Distribution and Sales Area

Table 22. Players Tasigna Products Offered

Table 23. Tasigna Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Tasigna Sales by Geographic Region (2017-2022) & (MT)

Table 27. Global Tasigna Sales Market Share Geographic Region (2017-2022)

Table 28. Global Tasigna Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Tasigna Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Tasigna Sales by Country/Region (2017-2022) & (MT)

Table 31. Global Tasigna Sales Market Share by Country/Region (2017-2022)

Table 32. Global Tasigna Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Tasigna Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Tasigna Sales by Country (2017-2022) & (MT)

Table 35. Americas Tasigna Sales Market Share by Country (2017-2022)

Table 36. Americas Tasigna Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Tasigna Revenue Market Share by Country (2017-2022)

Table 38. Americas Tasigna Sales by Type (2017-2022) & (MT)

Table 39. Americas Tasigna Sales Market Share by Type (2017-2022)

Table 40. Americas Tasigna Sales by Application (2017-2022) & (MT)

Table 41. Americas Tasigna Sales Market Share by Application (2017-2022)

Table 42. APAC Tasigna Sales by Region (2017-2022) & (MT)

Table 43. APAC Tasigna Sales Market Share by Region (2017-2022)

Table 44. APAC Tasigna Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Tasigna Revenue Market Share by Region (2017-2022)

Table 46. APAC Tasigna Sales by Type (2017-2022) & (MT)

Table 47. APAC Tasigna Sales Market Share by Type (2017-2022)

Table 48. APAC Tasigna Sales by Application (2017-2022) & (MT)

Table 49. APAC Tasigna Sales Market Share by Application (2017-2022)

Table 50. Europe Tasigna Sales by Country (2017-2022) & (MT)

Table 51. Europe Tasigna Sales Market Share by Country (2017-2022)

Table 52. Europe Tasigna Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Tasigna Revenue Market Share by Country (2017-2022)

Table 54. Europe Tasigna Sales by Type (2017-2022) & (MT)

Table 55. Europe Tasigna Sales Market Share by Type (2017-2022)

Table 56. Europe Tasigna Sales by Application (2017-2022) & (MT)

Table 57. Europe Tasigna Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Tasigna Sales by Country (2017-2022) & (MT)

Table 59. Middle East & Africa Tasigna Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Tasigna Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Tasigna Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Tasigna Sales by Type (2017-2022) & (MT)

Table 63. Middle East & Africa Tasigna Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Tasigna Sales by Application (2017-2022) & (MT)

Table 65. Middle East & Africa Tasigna Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Tasigna

Table 67. Key Market Challenges & Risks of Tasigna

Table 68. Key Industry Trends of Tasigna

Table 69. Tasigna Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Tasigna Distributors List

Table 72. Tasigna Customer List

Table 73. Global Tasigna Sales Forecast by Region (2023-2028) & (MT)

Table 74. Global Tasigna Sales Market Forecast by Region

Table 75. Global Tasigna Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Tasigna Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Tasigna Sales Forecast by Country (2023-2028) & (MT)

Table 78. Americas Tasigna Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Tasigna Sales Forecast by Region (2023-2028) & (MT)

Table 80. APAC Tasigna Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Tasigna Sales Forecast by Country (2023-2028) & (MT)

Table 82. Europe Tasigna Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Tasigna Sales Forecast by Country (2023-2028) & (MT)

Table 84. Middle East & Africa Tasigna Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Tasigna Sales Forecast by Type (2023-2028) & (MT)

Table 86. Global Tasigna Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Tasigna Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Tasigna Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Tasigna Sales Forecast by Application (2023-2028) & (MT)

Table 90. Global Tasigna Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Tasigna Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Tasigna Revenue Market Share Forecast by Application (2023-2028)

Table 93. Novartis Basic Information, Tasigna Manufacturing Base, Sales Area and Its Competitors

Table 94. Novartis Tasigna Product Offered

Table 95. Novartis Tasigna Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 96. Novartis Main Business

Table 97. Novartis Latest Developments

List of Figures

Figure 1. Picture of Tasigna

Figure 2. Tasigna Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tasigna Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Tasigna Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tasigna Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 50mg

Figure 10. Product Picture of 200mg

Figure 11. Product Picture of Other

Figure 12. Global Tasigna Sales Market Share by Type in 2021

Figure 13. Global Tasigna Revenue Market Share by Type (2017-2022)

Figure 14. Tasigna Consumed in Hospital

Figure 15. Global Tasigna Market: Hospital (2017-2022) & (MT)

Figure 16. Tasigna Consumed in Drugs Store

Figure 17. Global Tasigna Market: Drugs Store (2017-2022) & (MT)

Figure 18. Tasigna Consumed in Other

Figure 19. Global Tasigna Market: Other (2017-2022) & (MT)

Figure 20. Global Tasigna Sales Market Share by Application (2017-2022)

Figure 21. Global Tasigna Revenue Market Share by Application in 2021

Figure 22. Tasigna Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Tasigna Revenue Market Share by Company in 2021

Figure 24. Global Tasigna Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Tasigna Revenue Market Share by Geographic Region in 2021

Figure 26. Global Tasigna Sales Market Share by Region (2017-2022)

Figure 27. Global Tasigna Revenue Market Share by Country/Region in 2021

Figure 28. Americas Tasigna Sales 2017-2022 (MT)

Figure 29. Americas Tasigna Revenue 2017-2022 ($ Millions)

Figure 30. APAC Tasigna Sales 2017-2022 (MT)

Figure 31. APAC Tasigna Revenue 2017-2022 ($ Millions)

Figure 32. Europe Tasigna Sales 2017-2022 (MT)

Figure 33. Europe Tasigna Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Tasigna Sales 2017-2022 (MT)

Figure 35. Middle East & Africa Tasigna Revenue 2017-2022 ($ Millions)

Figure 36. Americas Tasigna Sales Market Share by Country in 2021

Figure 37. Americas Tasigna Revenue Market Share by Country in 2021

Figure 38. United States Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Tasigna Sales Market Share by Region in 2021

Figure 43. APAC Tasigna Revenue Market Share by Regions in 2021

Figure 44. China Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Tasigna Sales Market Share by Country in 2021

Figure 51. Europe Tasigna Revenue Market Share by Country in 2021

Figure 52. Germany Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Tasigna Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Tasigna Revenue Market Share by Country in 2021

Figure 59. Egypt Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Tasigna Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Tasigna in 2021

Figure 65. Manufacturing Process Analysis of Tasigna

Figure 66. Industry Chain Structure of Tasigna

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390